Supplementary Figure 3 from Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K-Ras Mutant Colorectal and Pancreatic Cancers

Autor: Giampaolo Tortora, Alberto Bardelli, Aldo Scarpa, Federica Di Nicolantonio, Sudhir Agrawal, Teresa Gelardi, Sonia Garofalo, Roberto Bianco, Vincenzo Damiano, Davide Melisi, Roberta Rosa

PDF file - 555KB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25fbfb5472db25fca9a11fe3c879bfa7
https://doi.org/10.1158/1078-0432.22445112.v1

Data from Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Autor: Giampaolo Tortora, Fortunato Ciardiello, Anderson Ryan, Adriana Albini, Roberto Benelli, Davide Melisi, Sandro De Falco, Valeria Tarallo, Sonia Garofalo, Teresa Gelardi, Gennaro Daniele, Vincenzo Damiano, Roberta Rosa, Roberto Bianco

Purpose: The resistance to selective EGFR inhibitors involves the activation of alternative signaling pathways, and Akt activation and VEGF induction have been described in EGFR inhibitor–resistant tumors. Combined inhibition of EGFR and other sign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6abb468924654bf44ec9e4bbd9047ff4
https://doi.org/10.1158/1078-0432.c.6517012

Supplementary Figures S1-S2 from Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Autor: Giampaolo Tortora, Fortunato Ciardiello, Anderson Ryan, Adriana Albini, Roberto Benelli, Davide Melisi, Sandro De Falco, Valeria Tarallo, Sonia Garofalo, Teresa Gelardi, Gennaro Daniele, Vincenzo Damiano, Roberta Rosa, Roberto Bianco

Supplementary Figures S1-S2 from Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ccfa70903b204751b8c4d62d33a04b
https://doi.org/10.1158/1078-0432.22439569.v1

Supplementary Figure 4 from Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K-Ras Mutant Colorectal and Pancreatic Cancers

Autor: Giampaolo Tortora, Alberto Bardelli, Aldo Scarpa, Federica Di Nicolantonio, Sudhir Agrawal, Teresa Gelardi, Sonia Garofalo, Roberto Bianco, Vincenzo Damiano, Davide Melisi, Roberta Rosa

PDF file - 204KB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33372df26fb0ee9339d36cf211313859
https://doi.org/10.1158/1078-0432.22445109.v1

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Autor: Valeria Tarallo, Roberto Bianco, Davide Melisi, Anderson J. Ryan, Vincenzo Damiano, Roberta De Rosa, Gennaro Daniele, Giampaolo Tortora, Sandro De Falco, Teresa Gelardi, Sonia Garofalo, Adriana Albini, Roberto Benelli, Fortunato Ciardiello

Publikováno v: Clinical cancer research
14 (2008): 5069–5080. doi:10.1158/1078-0432.CCR-07-4905
info:cnr-pdr/source/autori:Bianco R.; Rosa R.; Damiano V.; Daniele G.; Gelardi T.; Garofalo S.; Tarallo V.; De Falco S.; Melisi D.; Benelli R.;Albini A.; Ryan A.; Ciardiello F.; Tortora G./titolo:Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells/doi:10.1158%2F1078-0432.CCR-07-4905/rivista:Clinical cancer research (Print)/anno:2008/pagina_da:5069/pagina_a:5080/intervallo_pagine:5069–5080/volume:14

Purpose: The resistance to selective EGFR inhibitors involves the activation of alternative signaling pathways, and Akt activation and VEGF induction have been described in EGFR inhibitor–resistant tumors. Combined inhibition of EGFR and other sign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2159185920e0d462df022869adc266b1
https://doi.org/10.1158/1078-0432.ccr-07-4905